PeptidePedia The community reference

Bachem Holding (Suzhou): difference between revisions

Diff·revision 12 → 13·21:43, 6 Nov 2024

Difference between revision 12 and revision 13 of Bachem Holding (Suzhou). 3 lines changed; the page grew by 696 bytes.

Revision 12 — 03:22, 3 Nov 2024
EndotoxinEd (talk)
ce
2,633 bytes +536		Revision 13 — 21:43, 6 Nov 2024
ForgeryFinder (talk)
split overlong sentence
3,329 bytes +696
10The organisation is one of twenty covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}}10The organisation is one of twenty covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}}
1111
+12This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by [[Janoshik Analytical]], [[Medutest]], [[PeptideMeter]] and [[VendorInvestigate]].{{r|tally}}
+13
12== Corporate identity and history ==14== Corporate identity and history ==
13Registered in 2003, the organisation has one of the longer operating histories among the entities covered here.{{r|registry}} Suzhou hosts a large concentration of pharmaceutical and fine-chemical manufacturing within the Yangtze delta, and proximity to that cluster is the most that can reliably be said about its industrial context.15Registered in 2003, the organisation has one of the longer operating histories among the entities covered here.{{r|registry}} Suzhou hosts a large concentration of pharmaceutical and fine-chemical manufacturing within the Yangtze delta, and proximity to that cluster is the most that can reliably be said about its industrial context.
⋮⋮
19<ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref>21<ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref>
20<ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref>22<ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref>
+23<ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref>
21<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>24<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>
2225